Delivery Order SPE2DB22D3016-SPE2DB25FBCH9
- Not listed
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml pack quantities, with a ceiling value of $2,210. The contract, awarded on September 8, 2025, represents a firm fixed-price delivery order with a completion deadline of September 9, 2025. This award utilizes no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Provocholine inhalation solution in an 18 mL pack, with a ceiling value of $4,587.72 and a firm fixed price structure. The contract represents a non-competitive, competitively awarded delivery order with an ultimate completion date of June 2, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution Pack (18ML) with a ceiling value of $1,100.26 under a firm fixed-price contract type. This award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $11,511.90. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine Inhalation Solution in an 18ML pack format. This $25.1K firm fixed-price contract, issued on September 15, 2025, with a completion date of September 16, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCH9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which serves as a comprehensive pharmaceutical supply vehicle valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio of delivery orders through DLA encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This specific award for Provocholine inhalation solution supports the Defense Logistics Agency's mission to supply essential pharmaceutical products to defense and military healthcare programs. As a child contract under the larger SPE2DX IDC vehicle, this delivery order exemplifies the company's role as a prime pharmaceutical vendor serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 7/19/25 |